Cargando…

Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients

To investigate the clinical efficacy of neoadjuvant chemotherapy in the treatment of extremity soft tissue sarcomas (STSs). We retrospectively analyzed 28 patients with extremity STS that received 2 cycles of preoperative and 6 cycles of postoperative neoadjuvant chemotherapy between May 2009 and Ju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bing, Yu, Xiuchun, Xu, Songfeng, Xu, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291584/ https://www.ncbi.nlm.nih.gov/pubmed/26825914 http://dx.doi.org/10.1097/MD.0000000000002611

Ejemplares similares

VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
por: Moon, Ji Young, et al.
Publicado: (2017)

Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy
por: Kusaba, Hitoshi, et al.
Publicado: (2016)

Wide resection of soft tissue sarcomas after unplanned primary procedures: A long-term follow-up study
por: Kang, Jian, et al.
Publicado: (2020)

A nomogram to predict metastasis of soft tissue sarcoma of the extremities
por: Li, Ruo-He, et al.
Publicado: (2020)

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas
por: Long, Zuoyao, et al.
Publicado: (2023)

Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center
por: Khanmammadov, Nij̇at, et al.
Publicado: (2023)

Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy
por: Chen, Chuanben, et al.
Publicado: (2017)

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma
por: Luo, Zhiguo, et al.
Publicado: (2015)

Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study
por: Mi, Mi, et al.
Publicado: (2020)

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients
por: URAKAWA, HIROSHI, et al.
Publicado: (2014)

The current management of alveolar soft part sarcomas
por: Chang, Xiaojing, et al.
Publicado: (2021)

Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy: A case series and literature review
por: Huang, Huiqiong, et al.
Publicado: (2021)

Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
por: Wang, Bi-Cheng, et al.
Publicado: (2021)

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma
por: Scandurra, Giuseppa, et al.
Publicado: (2015)

Biological reconstruction in the treatment of extremity sarcoma in femur, tibia, and humerus
por: Yao, Weitao, et al.
Publicado: (2020)

Alveolar soft part sarcoma of the right calf: A case report
por: Wang, Bin, et al.
Publicado: (2020)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes
por: Xu, Ming, et al.
Publicado: (2014)

Neoadjuvant intra-arterial versus intravenous chemotherapy in colorectal cancer
por: Peng, Shu hui, et al.
Publicado: (2021)

Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994)

Lingual alveolar soft part sarcoma responsive to pazopanib: A case report
por: Yoshihiro, Tomoyasu, et al.
Publicado: (2017)

Rare cardiac metastasis of soft tissue sarcoma: A case report and literature review
por: Xiao, Jun, et al.
Publicado: (2018)

PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma
por: Li, Zhengtian, et al.
Publicado: (2021)

Prognostic value of pretreatment anemia in patients with soft tissue sarcoma: A meta-analysis
por: Shi, Landa, et al.
Publicado: (2021)

DNA methylation patterns–based subtype distinction and identification of soft tissue sarcoma prognosis
por: Li, Kai, et al.
Publicado: (2021)

Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study
por: Tian, Zhichao, et al.
Publicado: (2021)

Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer
por: Chavan, Devendra Manik, et al.
Publicado: (2017)

Effect of neoadjuvant chemotherapy on survival in patients with T1 high-grade non-muscle-invasive bladder cancer who underwent radical cystectomy
por: Huang, Long, et al.
Publicado: (2023)

Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
por: Tanaka, Kazuhiro, et al.
Publicado: (2022)

Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study
por: Marrari, Andrea, et al.
Publicado: (2020)

Therapeutic effect of neoadjuvant chemotherapy combined with curettage to treat distal femoral osteosarcoma: A case report
por: Lai, Qi, et al.
Publicado: (2017)

Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities
por: Aguiar, Samuel, et al.
Publicado: (2009)

Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer
por: Yeon, Sang Hoon, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Colorectal Cancer: Meta-analysis of Randomized Controlled Trials
por: Huang, Lei, et al.
Publicado: (2014)

Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: A PRISMA-compliant meta-analysis
por: Long, Yuming, et al.
Publicado: (2021)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy
por: Lee, Myung-Won, et al.
Publicado: (2020)

Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis
por: Xu, Jian, et al.
Publicado: (2019)

Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis
por: Xu, Ya-Ping, et al.
Publicado: (2015)

Adjuvant chemotherapy for locally advanced rectal cancer in elderly patients after neoadjuvant chemoradiotherapy and surgery: Toxicity and survival outcomes
por: Sun, Quanquan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qodnbn1dejuj326ohq6t9jv07f